2018 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 49 |
Best rating | 577 % |
Worst rating | -671 % |
New companies | 6 |
Negative Economic Capital Ratio | 19 of 49 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 12 of 49 |
Best rating | 577 % |
Worst rating | -671 % |
New companies | 6 |
Negative Economic Capital Ratio | 19 of 49 |
Navidea Biopharmaceuticals Inc. climbed 36 positions from 37 to 1 due to its excellent Net Income.FITLIFE BRANDS INC. lost 26 positions from 14 to 40 due to its bad Expenses.MARIMED INC. entered the 2018 ranking at rank 20, making it the best newcomer.
Revenues | 28.2 B |
Assets | 45.6 B |
Expenses | 27.1 B |
Stockholders Equity | 18.5 B |
Unprofitable Companies | 28 of 49 |
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Petroleum [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Aviation [...]
🚀 RealRate is raising! At realrate.ai, we’re revolutionizing financial ratings and analytics [...]
Last week, Dr. Holger Bartel, CEO of RealRate, pitched the business, showing how [...]
Earlier in September in Berlin, Dr. Holger Bartel, CEO of RealRate, hosted an [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Life [...]
Source: https://www.germanaccelerator.com Some incredible news at RealRate, folks! We have been [...]
Last week Dr. Holger Bartel, CEO at RealRate, took part in a very [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai